Yahoo
    OTC Markets OTCPK - Delayed Quote USD

    Valneva SE (INRLF)

    2.4900 0.0000 (0.00%)
    At close: October 30 at 4:00:00 PM EDT
    Loading Chart for INRLF
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    MHRA revokes approval for Valneva’s Ixchiq due to safety frailties

    MHRA revokes approval for Valneva’s Ixchiq due to safety frailties
    Pharmaceutical Technology 10d ago
    Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

    Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
    GlobeNewswire 17d ago
    Valneva Shares Fall as UK Withdraws Approval for Ixchiq Chikungunya Vaccine

    Valneva Shares Fall as UK Withdraws Approval for Ixchiq Chikungunya Vaccine
    InvestorsHub 23d ago
    VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback

    VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback
    Stocktwits 24d ago
    Valneva ADRs fall as UK revokes IXCHIQ marketing authorization

    Valneva ADRs fall as UK revokes IXCHIQ marketing authorization
    Investing.com 24d ago
    Valneva Provides Update on IXCHIQ® in the United Kingdom

    Valneva Provides Update on IXCHIQ® in the United Kingdom
    GlobeNewswire 24d ago
    Declaration of shares and voting rights - Status as of September 30, 2026

    Declaration of shares and voting rights - Status as of September 30, 2026
    GlobeNewswire 26d ago
    Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?

    Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
    Insider Monkey 1mo ago
    Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat

    Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat
    Insider Monkey 1mo ago
    Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva

    Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
    GlobeNewswire 1mo ago
    Declaration of shares and voting rights - Status as of August 31, 2026

    Declaration of shares and voting rights - Status as of August 31, 2026
    GlobeNewswire 1mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: